Provider review

Oak Longevity review: pricing, pharmacy, and evidence status

Released: · Last reviewed: · By Dr. Parmis

Oak Longevity offers GLP-1 medications through telehealth. Every price, credential and pharmacy claim below is labeled by evidence status and read date.

Oak Longevity has no usable published price on file. It does not name a dispensing pharmacy. On November 20, 2026 it scored 47.0/100 on GLP Ranked's v4.1 rubric, #13 of 15.

Rank and score

Oak Longevity scores 47.0 of 100, #13 of 15 scored programs (November 20, 2026). The table shows every sub-check, the points earned and why; the methodology explains each one.

Oak Longevity: v4.1 sub-checks, points earned and notes (read November 20-21, 2026)
IDCategorySub-checkPointsNote
PT1Pricing transparencyDrug price printed on the program's own page, read in the November 20, 2026 re-read0 of 5'from $109/mo', medicine not named
PT2Pricing transparencyPrice includes medication and care, or every required fee is printed beside it (2 if the program's own figures disagree)0 of 5
PT3Pricing transparencyPrice at every dose knowable: same price at every dose, or a full dose ladder0 of 5
PT4Pricing transparencyPlan term and billing interval stated (2 if the program's own pages disagree)5 of 5
CO1Clinical oversightPrescribing medical group named (9), network label (5), physician executive only (3), arrangement described (2)2 of 9
CO2Clinical oversightPrescribers' licensure or certification stated3 of 3
CO3Clinical oversightClinical lead (medical director or chief medical officer) named with credential0 of 3
PH1Pharmacy transparencyDispensing pharmacy named (10), class described but not named (4), described only (2); brand-only programs whose pages say prescriptions go to the pharmacy you choose (10)2 of 10
PH2Pharmacy transparencyPharmacy class (503A/503B) or licensure stated; brand-only programs that send prescriptions to your chosen pharmacy (5)5 of 5
SU1SupportTwo or more contact channels published (4), one (2)4 of 4
SU2SupportHow to cancel is stated3 of 3
SU3SupportRefund terms are stated (any stated condition under which money is refunded or credited)3 of 3
RD1Regulatory disclosureCompounded products described as not FDA-approved; brand-only programs (5)5 of 5
RD2Regulatory disclosureNo open FDA warning letter in FDA's index (read November 20, 2026)5 of 5
AC1AccessibilityWhere it operates stated clearly (4); vague or conflicting statements (2)4 of 4
AC2AccessibilityPayment beyond a card stated (HSA/FSA or pay-later)3 of 3
AC3AccessibilityCan start month to month without a multi-month commitment3 of 3
ANTotal annual costNo drug price printed, or medication not included0.0 of 2020 × benchmark ÷ cost
Total47.0 of 100

Strengths and limitations

Drawn from the sub-checks above, as read November 20-21, 2026.

  • Strength: Plan term and billing interval stated.
  • Strength: Prescribers' licensure or certification stated.
  • Strength: Pharmacy class.
  • Strength: Two or more contact channels published.
  • Limitation: Drug price printed on the program's own page, read in the November 20, 2026 re-read: 0 of 5 ('from $109/mo', medicine not named).
  • Limitation: Price includes medication and care, or every required fee is printed beside it: 0 of 5.
  • Limitation: Price at every dose knowable: same price at every dose, or a full dose ladder: 0 of 5.
  • Limitation: Prescribing medical group named: 2 of 9.
  • Limitation: Clinical lead: 0 of 3.
  • Limitation: Dispensing pharmacy named: 2 of 10.
  • Limitation: total annual cost scores 0.0 of 20 because no drug price is printed or medication is not included.

Pricing by plan

No currently usable priced plans are in our data set for Oak Longevity. Treat any advertised price as unverified until independently captured.

"Provider reported" means the figure comes from the company's own site or intake flow and has not been independently corroborated by GLP Ranked.

Clinical model

Described only: “telecommunications support to allow registered users to access health care providers who have a contractual relationship with Oak” (www.oaklovesyou.com, read 2026-11-10)

Accreditation: we have not verified any accreditation or certification claim for Oak Longevity against the issuing body. If a program cites one (for example LegitScript), check the issuer's public lookup before you rely on it.

Pharmacy & compliance

Pharmacy described but not named (read 2026-11-10) Pharmacy transparency is worth 15 of 100 points under our v4.1 rubric.

State availability

State-by-state availability is not independently verified.

Who this suits — and who it doesn't

Oak Longevity may suit patients who want a standard-dose program and are comfortable proceeding without a named dispensing pharmacy disclosed up front.It is a weaker fit for patients who need written proof of pharmacy accreditation before paying; ask the company for it.

Terms to check before you pay: whether cancellation and refund terms were found on its pages is recorded in sub-checks SU2 and SU3 above (read November 21, 2026); published support response times: not published.

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Sources

  1. FDA: Warning letters index (searched for this program) — Regulator database, captured 2026-11-20
  2. FDA: Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current October 1, 2026) — Regulator page, captured 2026-11-20
  3. FDA: Compounding: Inspections, Recalls, and other Actions (content current October 22, 2026) — Regulator list, captured 2026-11-21

Cite this page

GLP Ranked. "Oak Longevity review: pricing, pharmacy, and evidence status." https://glpranked.com/providers/oak-longevity/

GLP Ranked. "Oak Longevity review: pricing, pharmacy, and evidence status." https://glpranked.com/providers/oak-longevity/